Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
作者信息
Lu Hua, Lu Shi-Feng, Shen Wen-Yi, Hong Ming, Zhang Jian-Fu, Wang Li-Xia, Yang Hui, Li Jian-Yong
出版信息
Leuk Res. 2008 Nov;32(11):1776-9. doi: 10.1016/j.leukres.2008.03.022. Epub 2008 May 23.
Abstract
摘要
相似文献
1
Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.异基因骨髓间充质干细胞输注联合CAG方案治疗低增生复发性急性髓系白血病取得成功。
Leuk Res. 2008 Nov;32(11):1776-9. doi: 10.1016/j.leukres.2008.03.022. Epub 2008 May 23.
2
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.小剂量阿糖胞苷联合阿克拉霉素并联合粒细胞集落刺激因子预激（CAG方案）对老年急性髓系白血病患者预后的影响。
Leuk Res. 2007 Oct;31(10):1383-8. doi: 10.1016/j.leukres.2007.02.009. Epub 2007 Apr 8.
3
Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.低剂量阿糖胞苷和阿克拉霉素联合粒细胞集落刺激因子（CAG 方案）与 Hyper-CVAD 方案在复发/难治性费城染色体阴性急性淋巴细胞白血病中的疗效比较。
Leuk Res. 2015 Mar;39(3):323-8. doi: 10.1016/j.leukres.2015.01.003. Epub 2015 Jan 16.
4
Treatment of acute myelogenous leukaemia.急性髓性白血病的治疗。
J Intern Med Suppl. 1997;740:17-22.
5
CAG regimen enables relapsed or refractory T-cell acute lymphocytic leukemia patients to achieve complete remission: a report of six cases.CAG方案使复发或难治性T细胞急性淋巴细胞白血病患者获得完全缓解：6例报告
Am J Hematol. 2008 Feb;83(2):167-70. doi: 10.1002/ajh.21066.
6
[WT1 gene expression in patients with acute myelogenous leukemia or high risk myelodysplastic syndrome successfully treated with the CAG regimen].
Rinsho Ketsueki. 2002 Oct;43(10):960-2.
7
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.增加阿克拉霉素在小剂量阿糖胞苷与阿克拉霉素联合粒细胞集落刺激因子（CAG方案）中的剂量，可安全有效地治疗复发或难治性急性髓系白血病。
Int J Hematol. 2014;99(5):603-8. doi: 10.1007/s12185-014-1528-8. Epub 2014 Mar 13.
8
[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].[CHAG与CAG预激方案治疗难治性及复发性急性髓系白血病的对比评估]
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.
9
[Treatment of acute myelogenous leukemia].[急性髓细胞白血病的治疗]
Nihon Naika Gakkai Zasshi. 1992 Jul 10;81(7):1040-5.
Zotero 插件